Arbutus Biopharma Corporation ABUS Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's prepaid & other current?
- Arbutus Biopharma Corporation (ABUS) reported prepaid & other current of $1.73M in Q1 2026.
- How has Arbutus Biopharma Corporation's prepaid & other current changed year-over-year?
- Arbutus Biopharma Corporation's prepaid & other current decreased by 40.7% year-over-year, from $2.92M to $1.73M.
- What is the long-term trend for Arbutus Biopharma Corporation's prepaid & other current?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's prepaid & other current has grown at a -13.2% compound annual growth rate (CAGR), from $3.12M to $1.54M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.